Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 2/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3839029 | 0.84 | KDM4E (0.49) | ALDH1A1KDM4EMEN1CYP1A2CYP3A4 | |
| SCHEMBL20912024 | 0.82 | ALDH1A1 (0.36) | ALDH1A1KDM4EMEN1CYP1A2CYP3A4 | |
| SCHEMBL23529810 | 0.80 | KDM4E (0.36) | ALDH1A1KDM4EMEN1CYP1A2CYP3A4 | |
| SCHEMBL30468202 | 0.78 | FFAR1 (0.47) | ALDH1A1KDM4EMEN1CYP1A2CYP3A4 | |
| SCHEMBL2466535 | 0.78 | FFAR1 (0.47) | ALDH1A1KDM4EMEN1CYP1A2CYP3A4 | |
| SCHEMBL1626253 | 0.78 | FFAR1 (0.36) | ALDH1A1TSHRFFAR1 | |
| SCHEMBL10535351 | 0.77 | TSHR (0.45) | ALDH1A1KDM4EMEN1CYP1A2CYP3A4 | |
| SCHEMBL31562390 | 0.76 | CREBBP (0.35) | ALDH1A1KDM4EMEN1CYP1A2CYP3A4 | |
| SCHEMBL31349196 | 0.76 | TSHR (0.48) | ALDH1A1KDM4EMEN1CYP1A2CYP3A4 | |
| SCHEMBL1324387 | 0.76 | TSHR (0.48) | ALDH1A1KDM4EMEN1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243229-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-07-31 | — | — | US | disclosed |
| US-12297212-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-05-13 | — | — | US | disclosed |
| EP-4489555-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2025-01-08 | — | — | EP | disclosed |
| EP-3539959-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2024-12-11 | — | — | EP | disclosed |
| CN-115583902-B | Preparation method of alkynyl thioether compound | 江苏医药职业学院 | 2024-02-13 | — | — | CN | disclosed |
| US-20230365607-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230365607-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230365607-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| US-11746122-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-05 | — | — | US | disclosed |
| US-11746122-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-05 | — | — | US | disclosed |
| US-9006503-B2 | Organic electroluminescence devices containing substituted benzo[C]phenanthrenes | MERCK PATENT GMBH (DE) | 2015-04-14 | — | — | US | disclosed |
| US-20140155415-A1 | BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES | AMGEN INC. | 2014-06-05 | — | — | US | disclosed |
| US-8710284-B2 | Materials for organic electroluminescent devices containing substituted 10-benzo[c]phenanthrenes | MERCK PATENT GMBH (DE) | 2014-04-29 | — | — | US | disclosed |
| US-8710284-B2 | Materials for organic electroluminescent devices containing substituted 10-benzo[c]phenanthrenes | MERCK PATENT GMBH (DE) | 2014-04-29 | — | — | US | disclosed |
| EP-2694491-A1 | BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES | Amgen Inc. (US) | 2014-02-12 | — | — | EP | disclosed |
| WO-2012138776-A1 | BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES | AMGEN INC. (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20110288292-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-11-24 | — | — | US | disclosed |
| EP-2371829-A1 | Method for producing benzo-trithiophene or benzo-triselenophene derivatives | Nippon Kayaku Kabushiki Kaisha (JP) | 2011-10-05 | — | — | EP | disclosed |
| US-20100137617-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-06-03 | — | — | US | disclosed |
| EP-2147923-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | Nippon Kayaku Kabushiki Kaisha (JP) | 2010-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288292-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | DDT, DDC, BMI1 | ALDH1A1 356/4885KDM4E 1250/4885MEN1 1428/4885 |
| US-11746122-B2 | Organic electroluminescent materials and devices | GLRA3, GLRA2, LIFR | ALDH1A1 4154/4885KDM4E 1677/4885MEN1 2878/4885 |
| US-20250243229-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | F5, OR10J3, NPY4R | ALDH1A1 1417/4885KDM4E 1449/4885MEN1 908/4885 |
| US-12297212-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OR10J3 | ALDH1A1 2211/4885KDM4E 3068/4885MEN1 989/4885 |
| US-20100137617-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SCLY, TYR, CBS | ALDH1A1 716/4885KDM4E 3311/4885MEN1 769/4885 |
| US-20230365607-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OR10J3 | ALDH1A1 2211/4885KDM4E 3068/4885MEN1 989/4885 |
| US-20140155415-A1 | BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES | GCKR, GCK, PDK2 | ALDH1A1 3327/4885KDM4E 704/4885MEN1 4464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.